Alphagan · DIN 02236876 · 0.2% · Oph Sol
Limited Use, Reason for Use code 171, 172, 387 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 171, 172, 387 required
Write on scriptone applicable Reason for Use code, 171 or 172 or 387 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 171, 172, 387
Reason for Use code 171
As first line treatment of elevated intraocular pressure in patients who cannot tolerate an ophthalmic beta-blocking agent or where beta-blocking agents are contraindicated.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 172
As second line monotherapy or combination therapy in patients who do not have an adequate intraocular pressure lowering response to ophthalmic beta-blocking agents.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 387
For use as adjunctive therapy with an ophthalmic beta-blocking agent in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Alphagan · DIN 02236876
Manufacturer: Allergan Inc.; listing date 1998-12-31
Health Canada: Marketed since 2024-03-27 · brand ALPHAGAN · ATC S01EA05 BRIMONIDINE · form Solution · route Ophthalmic · ingredients BRIMONIDINE TARTRATE 0.2 %/W/V · company Abbvie corporation · schedule Prescription
Ministry pays: $1.1550 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02236876)
Source record
DIN 02236876: Alphagan
Raw flags: sec12=Y, sec3=Y
Item: 523600090; group id 614; item number 1581; lccId 00082; manufacturer id ALL
Source form: Oph Sol; strength: 0.2%
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $3.7970; ministry $1.1550
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02236876
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=60166
Interchangeable products
Brimonidine Tartrate Ophthalmic Solution · DIN 02515377 · $1.1550
Jamp-Brimonidine · DIN 02449226 · $1.1550
Med-Brimonidine · DIN 02507811 · $1.1550
Sandoz Brimonidine · DIN 02305429 · $1.1550
Shortage status: not checked (no credentials)